Gastrointestinal parameters that influence oral medications.

The successful functioning of oral medication depends primarily on how the gastrointestinal (Gl) tract processes drugs and drug delivery systems. Parameters such as regional pH, motility (and hence residence time), and brush border and colonic microflora enzymatic activity play an important role in the performance of orally administered dosage forms. In addition, medications are required to treat disease states that alter normal functions of the body. This review (which summarizes the symposium of the same title undertaken in the 2nd Jerusalem Conference on Pharmaceutical Sciences and Clinical Pharmacology, Jerusalem, Israel, May 1992) focuses on two aspects: (1) how some physiological parameters of the intestine can be manipulated to achieve control over drug absorption (P. Bass: alteration of the paracellular space of enterocytes with glucose to modulate the passive movement of drugs; E. Ziv: intestinal absorption of insulin) and spatial placement of drugs (D.R. Friend: use of colonic beta-glucosidases to target glycoside prodrugs of steroids to the large bowel; A. Rubinstein: specific degradation of polysaccharide matrices by colonic bacteria); and (2) how abnormalities of the Gl tract affect drug performance (J.B. Dressman: physiological and pathophysiological changes in upper Gl tract pH may lead to alterations in drug bioavailability; W. A. Ritschel: influence of diseases on the pharmacokinetics of drugs).

[1]  A. Sintov,et al.  Chondroitin sulfate: A potential biodegradable carrier for colon-specific drug delivery , 1992 .

[2]  A. Macpherson,et al.  Glucose and citrate reduce the permeability changes caused by indomethacin in humans. , 1992, Gastroenterology.

[3]  B. Korelitz Where Do We Stand on Drug Treatment for Ulcerative Colitis? , 1992, Annals of Internal Medicine.

[4]  N. Miyata,et al.  Evaluation of pH-independent sustained-release granules of dipyridamole by using gastric-acidity-controlled rabbits and human subjects , 1992 .

[5]  M. Ström,et al.  Pharmacokinetics of Tranexamic Acid in Patients with Ulcerative Colitis and in Healthy Volunteers After the Single Instillation of 2 g Rectally , 1992, Journal of clinical pharmacology.

[6]  W. Curatolo,et al.  C) Means to enhance penetration , 1992 .

[7]  D. Fleisher,et al.  Influence of D-glucose-induced water absorption on rat jejunal uptake of two passively absorbed drugs. , 1992, Journal of pharmaceutical sciences.

[8]  W. Ritschel,et al.  Peroral absorption of cefroxadine in patients within the first day after severe trauma: comparison to cefroxadine pharmacokinetics in fasted, healthy volunteers. , 1991, Methods and Findings in Experimental and Clinical Pharmacology.

[9]  D. Friend Colon-specific drug delivery , 1991 .

[10]  P. Gwilt,et al.  The Effects of Diabetes Mellitus on Pharmacokinetics and Pharmacodynamics in Humans , 1991, Clinical pharmacokinetics.

[11]  Jerome J. Schentag,et al.  Increased gastric pH and the bioavailability of fluconazole and ketoconazole. , 1991, Annals of Internal Medicine.

[12]  T. Tozer,et al.  Relative anti‐inflammatory effect of oral dexamethasone‐β‐D‐glucoside and dexamethasone in experimental inflammatory bowel disease in guinea‐pigs , 1991, The Journal of pharmacy and pharmacology.

[13]  J. Hanker,et al.  Gastrointestinal disease and oral contraception , 1990, American Journal of Obstetrics and Gynecology.

[14]  A. Rubinstein Microbially controlled drug delivery to the colon , 1990, Biopharmaceutics & drug disposition.

[15]  C. MacArthur,et al.  Misoprostol provides a colonic mucosal protective effect during acetic acid-induced colitis in rats. , 1990, Gastroenterology.

[16]  R. Roser,et al.  The Influence of Gastric Emptying on Droxicam Pharmacokinetics , 1989, Journal of clinical pharmacology.

[17]  W. Heizer,et al.  Effect of Altering Small Bowel Transit Time on Sustained Release Theophylline Absorption , 1989, Journal of clinical pharmacology.

[18]  G. Kearns,et al.  Clinical Pharmacokinetics in Infants and Children , 1989, Clinical pharmacokinetics.

[19]  J. Dressman,et al.  Elevation of gastric pH with ranitidine does not affect the release characteristics of sustained release ibuprofen tablets , 1988, Biopharmaceutics & drug disposition.

[20]  E. Ziv,et al.  Absorption of protein via the intestinal wall. A quantitative model. , 1987, Biochemical Pharmacology.

[21]  D. Neckers,et al.  A new approach to the oral administration of insulin and other peptide drugs. , 1986, Science.

[22]  D. Friend,et al.  Drug glycosides: potential prodrugs for colon-specific drug delivery. , 1985, Journal of medicinal chemistry.

[23]  D. Friend,et al.  A colon-specific drug-delivery system based on drug glycosides and the glycosidases of colonic bacteria. , 1984, Journal of medicinal chemistry.

[24]  M. Bendayan Protein A‐gold electron microscopic immunocytochemistry: Methods, applications, and limitations , 1984 .

[25]  P. Bass,et al.  Mechanisms of Action of Laxative Drugs , 1984 .

[26]  A. Onderdonk,et al.  A polymeric drug for treatment of inflammatory bowel disease. , 1983, Journal of medicinal chemistry.

[27]  E. Berry,et al.  The absorption of insulin from various regions of the rat intestine. , 1982, Life sciences.

[28]  P. Bass,et al.  Laxative-like effects of nonsteroidal anti-inflammatory drugs on intestinal fluid movement and membrane integrity. , 1982, Journal of Pharmacology and Experimental Therapeutics.

[29]  E. Berry,et al.  Bile salts promote the absorption of insulin from the rat colon. , 1981, Life sciences.

[30]  M. Kendall,et al.  Effects of inflammatory disease on plasma oxprenolol concentrations. , 1979, British medical journal.

[31]  C. Hawkins,et al.  Plasma propranolol concentrations and the erythrocyte sedimentation rate. , 1979, British Journal of Clinical Pharmacology.

[32]  D. Southgate,et al.  The digestion of pectin in the human gut and its effect on calcium absorption and large bowel function , 1979, British Journal of Nutrition.

[33]  B. Beermann,et al.  Malabsorption of Hydrochlorothiazide Following Intestinal Shunt Surgery , 1979, Clinical pharmacokinetics.

[34]  F. Sjöqvist,et al.  Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma alpha1 acid glycoprotein. , 1978, The New England journal of medicine.

[35]  P. Bass,et al.  Laxatives: an update on mechanism of action. , 1978, Life sciences.

[36]  T. Gaginella,et al.  Perfusion of rabbit colon with ricinoleic acid: dose-related mucosal injury, fluid secretion, and increased permeability. , 1977, Gastroenterology.

[37]  V. Go,et al.  Cytotoxicity of ricinoleic acid (castor oil) and other intestinal secretagogues on isolated intestinal epithelial cells. , 1977, Journal of Pharmacology and Experimental Therapeutics.

[38]  B. Creamer,et al.  Plasma levels and intestinal absorption of 25-hydroxyvitamin D in patients with small bowel resection. , 1977, Gut.

[39]  G. Greisen,et al.  Drug absorption and hepatic drug metabolism in patients with different types of intestinal shunt operation for obesity. A study with phenazone. , 1977, Scandinavian Journal of Gastroenterology.

[40]  R. Parsons Drug Absorption in Gastrointestinal Disease With Particular Reference to Malabsorption Syndromes , 1977, Clinical pharmacokinetics.

[41]  J. Kral,et al.  Oral contraceptives after intestinal bypass operations. , 1976, Journal of the American Medical Association (JAMA).

[42]  M. Mitchard,et al.  Plasma levels of propranolol in treated patients with coeliac disease and patients with Crohn's disease. , 1976, British medical journal.

[43]  P. Bass,et al.  The effects of sodium ricinoleate on small intestinal function and structure. , 1976, The Journal of clinical investigation.

[44]  P. Bass,et al.  Effects of ricinoleic and oleic acids on the digestive contractile activity of the canine small and large bowel. , 1976, Gastroenterology.

[45]  W. Nimmo Drugs, Diseases and Altered Gastric Emptying , 1976, Clinical pharmacokinetics.

[46]  P. Bass,et al.  Actions of ricinoleic acid and structurally related fatty acids of the gastrointestinal tract. I. Effects on smooth muscle contractility in vitro. , 1975, Journal of Pharmacology and Experimental Therapeutics.

[47]  R. Parsons,et al.  Absorption of two antibacterial drugs, cephalexin and co-trimoxazole, in malabsorption syndromes. , 1975, Journal of Antimicrobial Chemotherapy.

[48]  P. Bass,et al.  Inhibition of small intestinal mucosal and smooth muscle cell function by ricinoleic acid and other surfactants. , 1975, Life sciences.

[49]  R. Parsons,et al.  The absorption of antibiotics in adult patients with coeliac disease. , 1975, Journal of Antimicrobial Chemotherapy.

[50]  P. Bass,et al.  Inhibitory actions of laxatives on motility and water and electrolyte transport in the gastrointestinal tract. , 1975, The Journal of pharmacology and experimental therapeutics.

[51]  L. Prescott,et al.  The absorption of aspirin and paracetamol in patients with achlorhydria , 1974, The Journal of pharmacy and pharmacology.

[52]  M. Kristensen,et al.  The clinical effect of salazosulphapyridine (Salazopyrin r) in Crohn's disease. A controlled double-blind study. , 1974, Scandinavian journal of gastroenterology.

[53]  J. Nelson,et al.  Absorption of ampicillin and nalidixic acid by infants and children with acute shigellosis , 1972, Clinical pharmacology and therapy.

[54]  B. Drasar,et al.  Intestinal bacteria and the hydrolysis of glycosidic bonds. , 1971, Journal of medical microbiology.

[55]  P. Toghill,et al.  Folate deficiency and the pill. , 1971, British medical journal.

[56]  J. Hardcastle,et al.  The action of sennosides and related compounds on human colon and rectum 1 , 1970, Gut.

[57]  C. V. Winder,et al.  Relationship of the enterohepatic cycle to ulcerogenesis in the rat small bowel with flufenamic acid. , 1970, Gastroenterology.

[58]  B. Morris,et al.  The response of the hepatic lymph node of the sheep to swine influenza virus. , 1970, Australian Journal of Experimental Biology and Medical Science.

[59]  A. Tappel,et al.  LYSOSOMAL ENZYMES AND MUCOPOLYSACCHARIDES IN THE GASTRO-INTESTINAL TRACT OF THE RAT AND PIG. , 1965, Biochimica et biophysica acta.

[60]  A. Tappel,et al.  LYSOSOMAL ENZYMES OF RAT INTESTINAL MUCOSA , 1964, Journal of Cell Biology.

[61]  Smith Rs IRON ABSORPTION IN CYSTIC FIBROSIS. , 1964 .

[62]  M. Grossman,et al.  Fecal blood loss produced by oral and intravenous administration of various salicylates. , 1961, Gastroenterology.

[63]  D. Macdonald,et al.  Glycosidases in the Mammalian Alimentary Tract , 1959, Nature.

[64]  A. Ivy,et al.  On the fate of ingested pectin. , 1941 .